The Association Between Hypertensive Disorders in Pregnancy and the Risk of Developing Chronic Hypertension

Jiahao Xu1, Ting Li1, Yixiao Wang1

  • 1Department of Obstetrics and Gynecology, Nanjing Maternity and Child Health Care Hospital, Women's Hospital of Nanjing Medical University, Nanjing, China.

Insights

Hypertensive disorders in pregnancy (HDP), including preeclampsia (PE) and gestational hypertension (GH), significantly increase the risk of developing chronic hypertension later in life. This risk persists even after adjusting for other common risk factors.

Area of Science:

  • Obstetrics and Gynecology
  • Cardiovascular Health
  • Epidemiology

Background:

  • Hypertensive disorders in pregnancy (HDP) encompass conditions like preeclampsia (PE) and gestational hypertension (GH).
  • The long-term cardiovascular implications of HDP, particularly the risk of developing chronic hypertension, require comprehensive evaluation.
  • Understanding these associations is crucial for maternal health and preventative strategies.

Approach:

  • A systematic review and meta-analysis was conducted using data from PubMed, Embase, and Cochrane Library up to August 2021.
  • Twenty-one studies involving 634,293 patients were analyzed to determine the odds ratios (OR) for developing chronic hypertension.
  • Meta-regression and subgroup analyses were performed to explore heterogeneity and adjust for confounding factors like age and BMI.

Key Points:

  • Women with a history of HDP are 3.6 times more likely to develop chronic hypertension.
  • Gestational hypertension (GH) and preeclampsia (PE) are associated with 6.2 and 3.2 times increased likelihood, respectively.
  • Adjusted analyses confirmed that HDP and PE remain significant risk factors for chronic hypertension, with Asian populations showing a higher relative risk.

Conclusions:

  • Hypertensive disorders in pregnancy (HDP), including GH and PE, are independent risk factors for developing chronic hypertension.
  • The association between HDP and chronic hypertension is robust, persisting after adjustment for key demographic and clinical factors.
  • These findings underscore the importance of long-term cardiovascular monitoring for women with a history of HDP.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
46
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
67
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
66
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.6K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.0K